CTOs on the Move

Greenway Medical Technologies, Inc.

www.greenwaymedical.com

 
Greenway Medical Technologies provides the latest in ambulatory healthcare business solutions and services to 20000 healthcare providers and professionals nationwide, in 30 specialties and subspecialties, by enhancing the delivery of patient care
  • Number of Employees: 0-25
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

KSQ Therapeutics

KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed. The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates. KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts.

Wound Care Innovations

Wound Care Innovations is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Protectus Medical Devices

Protectus Medical Devices, Inc. is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BIO 101

BIO 101 is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.